TL
VIVO

TrueWealth LLC’s Meridian Bioscience Inc VIVO Stock Holding History

TrueWealth LLC’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		$3K Hold
150
– – ﹤0.01% 626
2020
Q1 		$1K Hold
150
– – ﹤0.01% 711
2019
Q4 		$1K Hold
150
– – ﹤0.01% 723
2019
Q3 		$1K Hold
150
– – ﹤0.01% 692
2019
Q2 		$2K Hold
150
– – ﹤0.01% 673
2019
Q1 		$3K Hold
150
– – ﹤0.01% 653
2018
Q4 		$3K Hold
150
– – ﹤0.01% 639
2018
Q3 		$2K Buy
+150
New +$2.33K ﹤0.01% 749

Other funds holding VIVO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

TrueWealth LLC's VIVO Position: Q2 2020 in Review

TrueWealth LLC held its Meridian Bioscience Inc (VIVO) position steady in Q2 2020 at 150 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #626.

TrueWealth LLC first reported a position in VIVO in Q3 2018 and has held it in 8 quarters since. 191 funds tracked by Wall St. Rank hold VIVO as of Q2 2020.

  • TrueWealth LLC held 150 shares of Meridian Bioscience Inc worth $3K as of Q2 2020.
  • TrueWealth LLC left its Meridian Bioscience Inc share count unchanged in Q2 2020.
  • Meridian Bioscience Inc made up ﹤0.01% of TrueWealth LLC's portfolio in Q2 2020, its #626 holding.
  • TrueWealth LLC first reported a position in Meridian Bioscience Inc in Q3 2018 and has held it in 8 quarters since.
  • 191 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q2 2020.

Based on TrueWealth LLC's 13F filing for Q2 2020, filed 15 Jul 2020.